Ottawa, ON – Peter Brenders, recently of Genzyme Canada, has been appointed the new president and CEO of BIOTECanada.
Mr Brenders joined Genzyme Canada in 2002 as the company’s health affairs executive responsible for government relations, external affairs and market access. Prior to Genzyme,he was the vice president of market access and health economics for Schering Canada. In this position, he was responsible for the company’s external and government relations, drug plan reimbursement of company products, market research, health management, and health economics research and publications.
Prior to that, he also worked at the Ontario Ministry of Health, and at KPMG.
He received his MBA in health services management from McMaster University. Prior to a brief stint in basic research at the Robarts Research Institute, he received a BSc in pharmacology and toxicology from the University of Western Ontario.